The physiological function of drug-transporting P-glycoproteins

Seminars in Cancer Biology

Volumn 8, Issue 3, 1997, Pages 161-170

  Schinkel, Alfred H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Blood brain barrier; Detoxification; Drug disposition; Multidrug resistance; P glycoprotein

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; DIGOXIN; DOMPERIDONE; GLYCOPROTEIN P; IVERMECTIN; LOPERAMIDE; MULTIDRUG RESISTANCE PROTEIN; ONDANSETRON; PACLITAXEL; TOXIC SUBSTANCE; VINBLASTINE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CELL VOLUME; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG TRANSPORT; GASTROINTESTINAL TRACT; HORMONE TRANSPORT; INTESTINE; KIDNEY; KNOCKOUT MOUSE; LIPID TRANSPORT; LIVER; MOUSE; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; NONHUMAN; PHYSIOLOGY; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0031158805     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1997.0068     Document Type: Conference Paper

References (77)

1. 1. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cells. Biochim Biophys Acta 455:152-162
2. 2. Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I (1995) Genetic analysis of the multidrug transporter. Annu Rev Genet 29:607-649
3. 3. Ruetz S, Gros P (1994) Functional expression of P-glycoproteins in secretory vesicles. J Biol Chem 269:12277-12284
4. 4. Schinkel AH, Wagenaar E, Mol CAAM, van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97:2517-2524
5. 5. De Graaf D, Sharma RC, Mechetner EB, Schimke RT, Roninson IB (1996) P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate up-take. Proc Natl Acad Sci USA 93:1238-1242
6. 6. Higgins CF, Gottesman MM (1992) Is the multidrug transporter a flippase? Trends Biochem Sci 17:18-21
7. 7. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T (1993) Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268:6077-6080
8. 1). J Pharm Exp Ther 263:840-845
9. 9. Schuetz EG, Schinkel AH, Relling MV, Schuetz JD (1996) P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci USA 93:4001-4005
10. 10. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JG, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus Maandag EC, te Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
11. 11. Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, Borst P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705
12. 12. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972
13. 13. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE (1989) Drug-resistance in multiple myeloma and Non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415-424
14. 14. Sikic BI (1993) Modulation of multidrug resistance: at the threshold. J Clin Oncol 11:1629-1635
15. 15. Licht T, Pastan I, Gottesman M, Herrmann F (1994) P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann Hematol 69:159-171
16. 16. Yuen AR, Sikic BI (1994) Multidrug resistance in lymphomas. J Clin Oncol 12:2453-2459
17. 17. Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155-199
18. 18. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381-389
19. 19. Van der Bliek AM, Kooiman PM, Schneider C, Borst P (1988) Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 71:401-411
20. 20. Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371-380
21. 21. Hsu SI-H, Lothstein L, Horwitz SB (1989) Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J Biol Chem 264:12053-12062
22. 22. Devault A, Gros P (1990) Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10:1652-1663
23. 23. Gros P, Raymond M, Bell J, Housman D (1988) Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 8:2770-2778
24. 24. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D-W, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83:4538-4542
25. 25. Schinkel AH, Roelofs MEM, Borst P (1991) Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51:2628-2635
26. 26. Buschman E, Gros P (1994) The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res 54:4892-4898
27. 27. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug resistance gene product in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738
28. 28. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissues. Mol Cell Biol 9:1346-1350
29. 29. Trezise AEO, Romano PR, Gill DR, Hyde SC, Buchwald M, Higgins CF (1992) The multidug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J 11:4291-4303
30. 30. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698
31. 31. Tanaka Y, Abe Y, Tsugu A, Takamiya Y, Akatsuka A, Tsuruo T, Yamazaki H, Ueyama Y, Sato O, Tamaoki N, Nakamura M (1994) Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas. Virchows Arch 425:133-138
32. 32. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265-269
33. 33. Arceci RJ, Croop JM, Horwitz SB, Housman D (1988) The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85:4350-4354
34. 34. Arceci RJ, Baas F, Raponi R, Horwitz SB, Housman D, Croop JM (1990) Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol Repr Dev 25:101-109
35. 35. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16. Cancer Res 48:1926-1929
36. 36. Axiotis CA, Guarch R, Merino MJ, Laporte N, Neumann RD (1991) P-glycoprotein expression is increased in human secretory and gestational endometrium. Lab Invest 65:577-581
37. 37. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248-24252
38. 38. Wolf DC, Horwitz SB (1992) P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer 52:141-146
39. 39. Bourgeois S, Gruol DJ, Newby RF, Rajah FM (1993) Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7:840-851
40. 40. Yang C-PH, Goei de Pinho S, Greenberger LM, Arceci RJ, Horwitz SB (1989) Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264:782-788
41. 41. Gottesman MM (1993) How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal foundation award lecture. Cancer Res 53:747-754
42. 42. Brown PC, Thorgeirsson SS, Silverman JA (1993) Cloning and regulation of the rat mdr2 gene. Nucl Acids Res 21:3885-3891
43. 43. Georges E, Bradley G, Gariepy J, Ling V (1990) Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci USA 87:152-156
44. 44. Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-95
45. 45. Neyfakh AA, Serpinskaya AS, Chervonsky AV, Apasov SG, Kazarov AR (1989) Multidrug resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp Cell Res 185:496-505
46. 46. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729-2734
47. 47. Klimecki WT, Futscher BW, Grogan TM, Dalton WS (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458
48. 48. Chong AS-F, Markham PN, Gebel HM, Bines SD, Coon JS (1993) Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother 36:133-139
49. 49. Witkowski JM, Li SP, Gorgas G, Miller RA (1994) Extrusion of the P-glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production. J Immunol 153:658-664
50. + hemopoietic stem cells. J Exp Med 175:1443-1447
51. 51. Zijlmans JMJM, Visser JWM, Kleiverda K, Kluin PM, Willemze R, Fibbe WE (1995) Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow repopulation ability. Proc Natl Acad Sci USA 92:8901-8905
52. 52. Raymond M, Gros P, Whiteway M, Thomas DY (1992) Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 256:232-234
53. 53. Rubartelli A, Cozzolino F, Talio M, Sitia R (1990) A novel secretory pathway for interleukin 1β, a protein lacking a signal sequence. EMBO J 9:1503-1510
54. 54. Muesch A, Hartmann E, Rohde K, Rubartelli A, Sitia R, Rapoport TA (1990) A novel pathway for secretory proteins? Trends Biochem Sci 15:86-88
55. 55. Valverde MA, Bond TD, Hardy SP, Taylor JC, Higgins CF, Altamirano J, Alvarez-Leefmans FJ (1996) The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J 15:4460-4468
56. 56. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-462
57. 57. Smith AJ, Timmermans-Hereijgers JLPM, Roelofsen B, Wirtz KWA, van Blitterswijk WJ, Smit JJM, Schinkel AH, Borst P (1994) The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 354:263-266
58. 58. Ruetz S, Gros P (1994b) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77:1071-1081
59. 59. Ruetz S, Gros P (1995) Enhancement of mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate; Implications for hepatic bile formation. J Biol Chem 270:25388-25395
60. 60. Van Helvoort A, Smith AJ, Sprang H, Fritsche I, Schinkel AH, Borst P, van Meer G (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517
61. 61. Debry P, Nash EA, Neklason DW, Metherall JE (1997) Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem 272:1026-1031
62. 62. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, van Deemter L, Smit JJM, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JMJM, Fibbe WE, Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033
63. 63. Gilman AG, Rall TW, Nies AS, Taylor P (1991) The Pharmacological Basis of Therapeutics. 1811 pp. McGraw-Hill Book Co, Singapore
64. 64. Cole SPC, Bhardway G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654
65. 65. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-552
66. 66. Childs S, Lin Yeh R, Georges E, Ling V (1995) Identification of a sister gene to P-glycoprotein. Cancer Res 55:2029-2034
67. 67. Goldstein GW, Betz AL (1986) The blood-brain barrier. Sci Am 255:70-79
68. 68. Levin VA (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684
69. 69. Bradbury MWB (1985) The blood-brain barrier. Circ Res 57:213-222
70. 70. Van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O (1996) Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein deficient mice. J Natl Cancer Inst 88:994-999
71. 71. Mayer U, Wagenaar E, Beijnen JH, Smit JW, Meijer DKF, van Asperen J, Borst P, Schinkel AH (1996) Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein. Br J Cancer 119:1038-1044
72. 72. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, Nooijen WJ, Beijnen JH, van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94:2031-2035
73. 73. Ames BN, Profet M, Gold LS (1990) Nature's chemicals and synthetic chemicals: comparative toxicology. Proc Natl Acad Sci USA 87:7782-7786
74. 74. Wacher VJ, Wu C-Y, Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinogen 13:129-134
75. 75. Schuetz EG, Beck WT, Schuetz JD (1996b) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately upregulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318
76. 76. Smith CAD, Smith G, Wolf CR (1994b) Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 30A:1921-1935
77. 77. Borst P, Schinkel AH (1997) Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 13:217-222